MedPath

A prospective observational study of switching to single-inhaler triple combinations in patients with obstructive pulmonary disease

Not Applicable
Conditions
Chronic obstructive pulmonary disease and bronchial asthma
Registration Number
JPRN-UMIN000043389
Lead Sponsor
Shizuoka General Hospital, respiratory medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with airway infection within 3 months 2. Patients who are contraindicative for single-inhaler triple therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A change of FEV1 after 8 weeks
Secondary Outcome Measures
NameTimeMethod
A change of symptom score, FVC, IC, respiratory impedance, FeNO after 8 weeks
© Copyright 2025. All Rights Reserved by MedPath